Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E P Prince

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 5, 2025
Tumor Hypoxia and CD8<sup>+</sup> T-Cell Infiltration in Patients With Advanced Laryngeal CancerJoshua D Smith, Elizabeth Gensterblum-Miller, David W A Forner, et al.
Head & Neck|April 19, 2013
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynxIrina Y Dobrosotskaya, Emily Bellile, Matthew E Spector, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck CancerMichelle L Mierzwa, Madhava Aryal, Choonik Lee, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 25, 2021
Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing BioselectionMolly E Heft Neal, Joshua D Smith, Andrew C Birkeland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2020
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapyBenjamin S Rosen, Joel R Wilkie, Yilun Sun, et al.
Head & Neck|March 18, 2023
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancerJoshua D Smith, Megan L Ludwig, Apurva D Bhangale, et al.
Advances in Radiation Oncology|August 21, 2025
Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx CancerSamuel Nicholas Regan, Jennifer Shah, Krithika Suresh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 3, 2019
Assessment of Intraoperative Nerve Monitoring Parameters Associated With Facial Nerve Outcome in Parotidectomy for Benign DiseaseCatherine T Haring, Susan E Ellsperman, Bruce M Edwards, et al.
Oral Oncology|November 2, 2022
Prognostic value of CD103<sup>+</sup> tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinomaJoshua D Smith, Emily L Bellile, Susan E Ellsperman, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 5, 2025
Tumor Hypoxia and CD8<sup>+</sup> T-Cell Infiltration in Patients With Advanced Laryngeal CancerJoshua D Smith, Elizabeth Gensterblum-Miller, David W A Forner, et al.
Head & Neck|April 19, 2013
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynxIrina Y Dobrosotskaya, Emily Bellile, Matthew E Spector, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck CancerMichelle L Mierzwa, Madhava Aryal, Choonik Lee, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 25, 2021
Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing BioselectionMolly E Heft Neal, Joshua D Smith, Andrew C Birkeland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2020
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapyBenjamin S Rosen, Joel R Wilkie, Yilun Sun, et al.
Head & Neck|March 18, 2023
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancerJoshua D Smith, Megan L Ludwig, Apurva D Bhangale, et al.
Advances in Radiation Oncology|August 21, 2025
Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx CancerSamuel Nicholas Regan, Jennifer Shah, Krithika Suresh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 3, 2019
Assessment of Intraoperative Nerve Monitoring Parameters Associated With Facial Nerve Outcome in Parotidectomy for Benign DiseaseCatherine T Haring, Susan E Ellsperman, Bruce M Edwards, et al.
Oral Oncology|November 2, 2022
Prognostic value of CD103<sup>+</sup> tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinomaJoshua D Smith, Emily L Bellile, Susan E Ellsperman, et al.
Pageof 6